Ligand validation:8XWO

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 8XWO designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8XWO_C8E_A_402	94%	77%	0.046	0.989	0.45	0.46	-	-	2	0	76%	1
8XWO_C8E_A_403	92%	77%	0.04	0.983	0.52	0.41	-	-	2	0	71%	1
8XWO_C8E_B_402	86%	79%	0.03	0.992	0.5	0.36	-	-	0	0	48%	1
8XWO_C8E_F_402	86%	68%	0.031	0.991	0.59	0.63	-	-	0	0	48%	1
8XWO_C8E_D_402	86%	71%	0.031	0.991	0.56	0.55	-	-	1	0	48%	1
8XWO_C8E_C_401	84%	83%	0.054	0.985	0.46	0.33	-	-	0	0	62%	1
8XWO_C8E_B_401	81%	74%	0.048	0.994	0.54	0.46	-	-	0	0	48%	1
5MDO_C8E_F_404	60%	76%	0.131	0.949	0.38	0.56	-	-	0	0	81%	1
7EQR_C8E_A_403	53%	75%	0.119	0.956	0.51	0.47	-	-	0	0	57%	1
5MDR_C8E_E_401	48%	86%	0.113	0.931	0.24	0.48	-	-	0	0	57%	1
7EQM_C8E_A_409	45%	87%	0.15	0.958	0.35	0.35	-	-	1	0	57%	1
8JUQ_C8E_C_405	34%	86%	0.161	0.906	0.45	0.27	-	-	0	0	67%	1
2VQI_C8E_B_1638	100%	84%	0.037	0.989	0.38	0.39	-	-	0	0	100%	1
2GR7_C8E_D_1342	83%	75%	0.098	0.955	0.42	0.56	-	-	2	0	100%	1
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	4	0	100%	1
3QRC_C8E_B_1	76%	86%	0.113	0.95	0.37	0.36	-	-	0	0	100%	1
3RGN_C8E_A_800	76%	74%	0.112	0.947	0.34	0.66	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.